» Articles » PMID: 9426016

Intravascular Ultrasound Predictors of Angiographic Restenosis in Lesions Treated with Palmaz-Schatz Stents

Overview
Date 1998 Jan 13
PMID 9426016
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study sought to evaluate the clinical, procedural, preinterventional and postinterventional quantitative coronary angiographic (QCA) and intravascular ultrasound (IVUS) predictors of restenosis after Palmaz-Schatz stent placement.

Background: Although Palmaz-Schatz stent placement reduces restenosis compared with balloon angioplasty, in-stent restenosis remains a major clinical problem.

Methods: QCA and IVUS studies were performed before and after intervention (after stent placement and high pressure adjunct balloon angioplasty) in 382 lesions in 291 patients treated with 476 Palmaz-Schatz stents for whom follow-up QCA data were available 5.5 +/- 4.8 months (mean +/- SD) later. Univariate and multivariate predictors of QCA restenosis (> or = 50% diameter stenosis at follow-up, follow-up percent diameter stenosis [DS] and follow-up minimal lumen diameter [MLD]) were determined.

Results: Three variables were the most consistent predictors of the follow-up angiographic findings: ostial lesion location, IVUS preinterventional lesion site plaque burden (plaque/total arterial area) and IVUS assessment of final lumen dimensions (whether final lumen area or final MLD). All three variables predicted both the primary (binary restenosis) and secondary (follow-up MLD and follow-up DS) end points. In addition, a number of variables predicted one or more but not all the end points: 1) restenosis (IVUS preinterventional lumen and arterial area); 2) follow-up DS (QCA lesion length); and 3) follow-up MLD (QCA lesion length and preinterventional MLD and DS and IVUS preinterventional lumen and arterial area).

Conclusions: Ostial lesion location and IVUS preinterventional plaque burden and postinterventional lumen dimensions were the most consistent predictors of angiographic in-stent restenosis.

Citing Articles

Ostial right coronary artery lesion morphology and outcomes after treatment with drug-eluting stents.

Yamamoto K, Sato T, Salem H, Chen Y, Matsumura M, Bletnitsky N EuroIntervention. 2024; 20(3):e207-e215.

PMID: 38343369 PMC: 10836391. DOI: 10.4244/EIJ-D-23-00406.


Propensity-matched analysis of long-term clinical results after ostial circumflex revascularisation.

Espejo-Paeres C, Vedia O, Wang L, Hennessey B, Mejia-Renteria H, McInerney A Heart. 2023; 109(17):1302-1309.

PMID: 37217296 PMC: 10423548. DOI: 10.1136/heartjnl-2022-322204.


Stent expansion evaluated by optical coherence tomography and subsequent outcomes.

Lee B, Baraki T, Kim B, Lee Y, Lee S, Hong S Sci Rep. 2023; 13(1):3781.

PMID: 36882449 PMC: 9992647. DOI: 10.1038/s41598-023-30717-6.


Willis Covered Stent for Treating Intracranial Pseudoaneurysms of the Internal Carotid Artery: A Multi-Institutional Study.

Lu D, Ma T, Zhu G, Zhang T, Wang N, Lei H Neuropsychiatr Dis Treat. 2022; 18:125-135.

PMID: 35125870 PMC: 8811267. DOI: 10.2147/NDT.S345163.


Association of stent diameter and target vessel revascularization in patients undergoing percutaneous coronary intervention: a secondary retrospective analysis based on a Chinese cohort study.

Xu T, Feng B, Zheng Z, Li L, Zeng W, Wang D BMC Cardiovasc Disord. 2021; 21(1):402.

PMID: 34418965 PMC: 8379726. DOI: 10.1186/s12872-021-02212-1.